Natasha Giordano - Net Worth and Insider Trading
Natasha Giordano Net Worth
The estimated net worth of Natasha Giordano is at least $926 dollars as of 2024-11-29. Natasha Giordano is the Director of Aceto Corp and owns about 8,057 shares of Aceto Corp (ACETQ) stock worth over $925. Natasha Giordano is also the CEO of PLx Pharma Winddown Corp and owns about 5,186 shares of PLx Pharma Winddown Corp (PLXPQ) stock worth over $1. Details can be seen in Natasha Giordano's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Natasha Giordano has not made any transactions after 2022-03-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Natasha Giordano
Natasha Giordano Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Natasha Giordano owns 4 companies in total, including Matinas BioPharma Holdings Inc (MTNB) , PLx Pharma Winddown Corp (PLXPQ) , and Aceto Corp (ACETQ) among others .
Click here to see the complete history of Natasha Giordano’s form 4 insider trades.
Insider Ownership Summary of Natasha Giordano
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
MTNB | Matinas BioPharma Holdings Inc | 2020-09-14 | director |
PLXPQ | PLx Pharma Winddown Corp | 2022-03-15 | director & Chief Executive Officer |
ACETQ | Aceto Corp | 2019-10-01 | director |
2014-01-01 | director & CEO and President |
Natasha Giordano Latest Holdings Summary
Natasha Giordano currently owns a total of 2 stocks. Among these stocks, Natasha Giordano owns 8,057 shares of Aceto Corp (ACETQ) as of March 4, 2015, with a value of $925 and a weighting of 99.89%. Natasha Giordano also owns 5,186 shares of PLx Pharma Winddown Corp (PLXPQ) as of March 15, 2022, with a value of $1 and a weighting of 0.11%.
Latest Holdings of Natasha Giordano
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
ACETQ | Aceto Corp | 2015-03-04 | 8,057 | 0.11 | 925 |
PLXPQ | PLx Pharma Winddown Corp | 2022-03-15 | 5,186 | 0.00 | 1 |
Holding Weightings of Natasha Giordano
Natasha Giordano Form 4 Trading Tracker
According to the SEC Form 4 filings, Natasha Giordano has made a total of 0 transactions in Aceto Corp (ACETQ) over the past 5 years. The most-recent trade in Aceto Corp is the sale of 2,164 shares on March 4, 2015, which brought Natasha Giordano around $45,271.
According to the SEC Form 4 filings, Natasha Giordano has made a total of 1 transactions in PLx Pharma Winddown Corp (PLXPQ) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in PLx Pharma Winddown Corp is the acquisition of 4,100 shares on March 15, 2022, which cost Natasha Giordano around $14,965.
Insider Trading History of Natasha Giordano
- 1
Natasha Giordano Trading Performance
GuruFocus tracks the stock performance after each of Natasha Giordano's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Natasha Giordano is -42.58%. GuruFocus also compares Natasha Giordano's trading performance to market benchmark return within the same time period. The performance of stocks bought by Natasha Giordano within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Natasha Giordano's insider trading performs compared to the benchmark.
Performance of Natasha Giordano
Natasha Giordano Ownership Network
Natasha Giordano Owned Company Details
What does Matinas BioPharma Holdings Inc do?
Who are the key executives at Matinas BioPharma Holdings Inc?
Natasha Giordano is the director of Matinas BioPharma Holdings Inc. Other key executives at Matinas BioPharma Holdings Inc include Chief Business Officer Thomas Hoover , director & Chief Executive Officer Jerome D Jabbour , and Chief Financial Officer Keith A Kucinski .
Matinas BioPharma Holdings Inc (MTNB) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Matinas BioPharma Holdings Inc (MTNB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Matinas BioPharma Holdings Inc (MTNB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Matinas BioPharma Holdings Inc (MTNB)'s detailed insider trading history can be found in Insider Trading Tracker table.
Matinas BioPharma Holdings Inc Insider Transactions
Natasha Giordano Mailing Address
Above is the net worth, insider trading, and ownership report for Natasha Giordano. You might contact Natasha Giordano via mailing address: 8285 El Rio Street, Suite 130, Houston Tx 77054.